Le Lézard
Classified in: Health, Covid-19 virus
Subjects: CHI, SVY

Experts from Across the U.S. Issue Back-To-School Safety Guidelines for Pediatric Solid Organ Transplant Recipients


PHILADELPHIA, Aug. 4, 2020 /PRNewswire/ -- As school districts look ahead to a very different school year, pediatric infectious disease experts from across the United States convened to outline back-to-school safety guidelines for solid organ transplant (SOT) recipients. The group, led by Kevin J. Downes, MD, attending physician in the Division of Pediatric Infectious Diseases at Children's Hospital of Philadelphia (CHOP), published their recommendations today in the Journal of the Pediatric Infectious Diseases Society.

Throughout the COVID-19 pandemic, pediatric SOT patients have been categorized as high-risk due to their use of immunosuppressive medications, frequent presence of additional medical issues, and elevated risk for more severe outcomes from other viral respiratory infections. While there is no specific evidence that pediatric SOT recipients fare worse from COVID-19, parents of SOT patients are undoubtedly nervous to send their children back to school in the fall.

As a result, parents of transplant recipients need clear guidance regarding return to school decisions and what approaches, if any, they or their schools should take to protect their immunocompromised child. In addition to these health-related considerations, many are also weighing the notable academic, social, and emotional benefits of school attendance.

"We listened to the questions families brought to us, and to their transplant providers, and drafted a set of recommendations around their concerns," said Dr. Downes. "For the majority of pediatric SOT recipients, the benefits of attending school will probably outweigh the risks. However, the final decision is a matter of shared decision-making among families, transplant professionals, and educators, and depends on many factors, including the child's clinical risk, COVID-19 cases in the community, and preparedness of both the child and the school to adhere to recommended precautions to prevent viral transmission."

The consensus statements are grouped in three areas: 1) SOT patient-specific risk factors, 2) community transmission and public health responses, and 3) school-related interventions. Only questions pertaining to school attendance in kindergarten through 12th grade in U.S. schools were considered. Questions include topics related to masking, virtual learning, and infection prevention measures.

The COVID-19 pandemic has created unprecedented circumstances and unique challenges for vulnerable children around the world. While caregivers are grappling with difficult decisions regarding returning to schools, public health officials, local health departments, and school administrators are working hard to make returning to school as safe as possible. Dr. Downes and his colleagues fully support efforts to allow all children to safely return to in-person education this academic year and have provided recommendations for transplant patients, families, and providers to help meet this goal.

About Children's Hospital of Philadelphia: Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. In addition, its unique family-centered care and public service programs have brought the 546-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu

Contact: Camillia Travia
Children's Hospital of Philadelphia
(267) 426-6251 (office)
(425) 492-5007 (cell)
[email protected]

 

SOURCE Children's Hospital of Philadelphia


These press releases may also interest you

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...

at 12:00
Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), an official journal of the...

at 11:45
Today at ACP's annual meeting, Internal Medicine Meeting 2024, Annals of Internal Medicine presented three breaking scientific research articles during a live scientific plenary session that featured the authors of those articles. The articles were...

at 11:43
- Cochlear Limited , the global leader in implantable hearing...

at 11:35
The Bone Health and Osteoporosis Foundation (BHOF) announced today its call for nominees for the newly created Robert F. Gagel, M.D. Community Leadership Award. The award's intent is to recognize healthcare professionals who are instrumental in...

at 11:33
Celebrating the 40th anniversary of The Glaucoma Foundation, writer, performer and producer David Letterman was front and center at TGF's April 18th Gala in New York City, where he received the Foundation's inaugural Chairman's Spotlight Award....



News published on and distributed by: